British American Tobacco Indonesia - The health risks of smoking
Quick Navigation
Jump to content
Helping consumers make informed choices
For a business like ours, it is imperative that we provide clear and meaningful information about the different risk profiles of our products to help consumers make informed choices.
As well as being the most common way of consuming tobacco, cigarettes are also the most harmful. Burning any plant material like tobacco turns thousands of plant-based compounds into thousands of new compounds, some of which are toxic. Inhaling the smoke that contains these toxicants causes the overwhelming majority of smoking-related diseases.
Along with the pleasures of smoking, there are real risks of serious diseases such as lung cancer, respiratory disease and heart disease, and for many people, smoking is difficult to quit
What people should consider about the risks:
Tobacco heating products contain blended or processed tobacco, just like regular cigarettes, but instead of being burned the tobacco is heated to vaporise the nicotine and some tobacco flavouring compounds into an aerosol that can be inhaled. This creates fewer smoke toxicants than conventional cigarettes and therefore has the potential to be less risky.
We plan to begin consumer trials of a tobacco heating product by the end of 2015 and have our first product in a test market in 2016.
Snus is a type of low-toxicant oral tobacco that we currently sell in Sweden and Norway. It is proven by independent health studies to be substantially less risky than smoking.
Studies of snus use in Sweden suggest that it does not lead to an increasing risk of lung cancer and chronic obstructive pulmonary disease, two diseases strongly associated with cigarette smoking. This is not surprising, given that consuming snus does not involve inhaling smoke.
While research on various other forms of smokeless tobacco has found associations with oral cancer, research to date on Swedish-style snus suggests no increase in risk overall.
E-cigarettes and other nicotine inhalation products deliver nicotine to the user in the form of vapour. So, when manufactured to robust quality and safety standards, they are considered to be substantially less risky than regular cigarettes.
There are some public health organisations that have voiced concerns that not enough is known about the health risks of e-cigarettes and we agree that more research is needed into the long-term effects of their use. This is why we are already conducting our own research, submitting the results for peer-review and openly sharing our findings with scientists, regulators and other relevant bodies.